Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer

Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer  NEW YORK – January 2, 2019 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and…